Twist Bioscience Corporation TWST
182.83
(1.20)
(0.65%)
as of 25 Sep
- Market cap
- $12.4B
- P/E
- 0.0×
Follow TWST
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (29.59%) | (18.16%) | (16.79%) | (16.43%) |
+8 more TTM periods Free account |
|
| (20.78%) | (12.78%) | (12.29%) | (12.37%) | ||
ROIC |
(30.83%) | (29.07%) | (30.78%) | (33.33%) | |
Return on Tangible Assets |
(43.69%) | (25.83%) | (23.31%) | (22.59%) | |
Average Days of Receivables |
54.99 | 57.18 | 46.67 | 55.27 | |
Free Cash Flow per Share |
(1.53) | (1.54) | (1.42) | (1.26) | |
Free Cash Flow |
(95.62) | (95.04) | (86.72) | (75.63) | |
Capital Expenditures |
(42.55) | (39.45) | (35.71) | (28.00) | |
Piotroski F-Score |
4.00 | 5.00 | 5.00 | 4.00 | |
| Other line items | |||||
Cash ROIC |
(8.46%) | (8.66%) | (7.62%) | (6.61%) | |
Accounts Receivable Turnover |
7.52 | 7.18 | 8.76 | 8.19 | |
Accounts Payable Turnover |
14.29 | 17.26 | 18.95 | 29.17 | |
Inventory Turnover |
6.79 | 7.22 | 6.71 | 7.08 | |
Average Days of Payables |
29.99 | 27.31 | 24.07 | 21.82 | |
Days of Inventory on Hand |
61.88 | 62.33 | 63.44 | 55.68 | |
Tax Rate |
0.01 | 0.01 | 0.01 | 0.01 | |
Research and Development Expense of Revenue |
16.64% | 17.56% | 19.44% | 21.32% | |
Selling, General and Administrative Expense of Revenue |
67.23% | 66.66% | 66.54% | 65.59% | |
Share Based Compensation of Revenue |
15.39% | 15.71% | 16.79% | 17.12% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.39 | 0.68 | 0.67 | 0.61 | |
Depreciation/Fixed assets |
0.23 | 0.22 | 0.23 | 0.24 | |
Capex/Depreciation |
(1.68) | (1.60) | (1.45) | (1.13) | |
Revenue per Share |
6.92 | 6.64 | 6.41 | 6.30 | |
Operating CF per Share |
(0.85) | (0.90) | (0.84) | (0.80) | |
Capex per Share |
(0.68) | (0.64) | (0.58) | (0.47) | |
Capex to Sales |
0.10 | 0.10 | 0.09 | 0.07 | |
Net Profit Margin |
(31.66%) | (19.85%) | (19.56%) | (20.63%) |
Columns are period end dates